Maze Therapeutics (MAZE) Gross Profit (2025 - 2026)
Maze Therapeutics' (MAZE) quarterly Gross Profit came in at $18.2 million in Q1 2026, up 1633.95% year-on-year from $1.1 million in Q1 2025, and up 1633.95% quarter-over-quarter from -$1.2 million in Q1 2025.
Maze Therapeutics (MAZE) Gross Profit (2025 - 2026) Analysis & Trends
Maze Therapeutics has disclosed Gross Profit across 2 years of filings, most recently posting $18.2 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Maze Therapeutics | 1.39 Bn | 1.39 Bn | 18.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.21 Mn |
| Mar 31, 2026 | 18.21 Mn |
| Mar 31, 2025 | -1.19 Mn |
| Mar 31, 2025 | -1.19 Mn |